Update on new treatments and developments in childhood brain tumors-Reference-Cited by-同舟云学术

Update on new treatments and developments in childhood brain tumors

Published:2007-12 Issue:6 Volume:19 Page:670-674
ISSN:1040-8703
Container-title:Current Opinion in Pediatrics
language:en
Short-container-title:

Author:

Partap Sonia,Fisher Paul Graham

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pediatrics, Perinatology and Child Health

Reference29 articles.

1. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group study;Packer;J Clin Oncol,1999

2. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group;Albright;Neurosurgery,1996

3. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group;Robertson;J Neurosurg,2006

4. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma;Packer;J Clin Oncol,2006

5. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial;Gajjar;Lancet Oncol,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel integrated gene coexpression analysis approach reveals a prognostic three-transcription-factor signature for glioma molecular subtypes;BMC Systems Biology;2016-08

2. Antitumour activity of 2-dihydroailanthone from the bark of Ailanthus altissima against U251;Pharmaceutical Biology;2016-03-09

3. Neuro-Ophthalmologic Manifestations of Systemic and Intracranial Disease;Pediatric Neuro-Ophthalmology;2016

4. Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway;Molecular Medicine Reports;2015-12-10

5. A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma;Pediatric Blood & Cancer;2015-07-31